ask andreas moritz glutathione Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy Ann-Kathrin LEDERER | Visceral surgeon
Ann Kathrin LEDERER Visceral surgeon Universittsmedizin der Johannes Gutenberg Universitt Mainz, Mainz Department of General, Visceral and Transplantation Surgery Research profile Biomolecules December 2024 Browse Articles Phenotypes on demand via switchable target protein degradation in multicellular organisms Nature Communications Hepatic OATP1B Transporters and Nuclear Receptors PXR and CAR: Interplay, Regulation of Drug Disposition Genes, and Single Nucleotide Polymorphisms Molecular Pharmaceutics
Pay in 4 interest-free payments of $5.53 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23



